Eam Investors, LLC Cara Therapeutics, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$16.11 - $25.98 $1.63 Million - $2.63 Million	-101,336 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$18.28 - $26.91 $1.85 Million - $2.73 Million	101,336 New	101,336 $1.85 Million
Q4 2018 Feb 13, 2019	SELL	$12.45 - $23.47 $634,962 - $1.2 Million	-51,001 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$17.57 - $23.95 $896,087 - $1.22 Million	51,001 New	51,001 $1.22 Million

826K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $257M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.